Ming-Kuei Jang
Amministratore Delegato presso Aprinoia Therapeutics, Inc.
Profilo
Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer.
He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations.
Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC.
In the past, he worked as an Associate Director at Glaxosmithkline China Ltd.
from 2010 to 2012.
Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.
Posizioni attive di Ming-Kuei Jang
| Società | Posizione | Inizio |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Amministratore Delegato | 20/05/2015 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Fondatore | 01/01/2015 |
| APRINOIA Therapeutics LLC | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Ming-Kuei Jang
| Società | Posizione | Fine |
|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | 01/03/2012 |
Formazione di Ming-Kuei Jang
| Boston University School of Medicine | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Aprinoia Therapeutics, Inc.
Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Health Technology |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| APRINOIA Therapeutics LLC | |
| Glaxosmithkline China Ltd. |
- Borsa valori
- Insiders
- Ming-Kuei Jang
